120 related articles for article (PubMed ID: 36187395)
21. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
22. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
[TBL] [Abstract][Full Text] [Related]
23. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
[TBL] [Abstract][Full Text] [Related]
24. A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection.
Kalimutho M; Del Vecchio Blanco G; Cretella M; Mannisi E; Sileri P; Formosa A; Pallone F; Federici G; Bernardini S
Int J Colorectal Dis; 2011 May; 26(5):583-92. PubMed ID: 21225430
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of sessile serrated lesion in the colorectum and its relationship to synchronous colorectal advanced neoplasia: a systemic review and meta-analysis.
Shiu SI; Kashida H; Komeda Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1495-1504. PubMed ID: 33470706
[TBL] [Abstract][Full Text] [Related]
26. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
27. Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil.
Teixeira CR; Bonotto ML; Lima JP; Figueiredo LF; Conrado L; Frasca C
Ann Gastroenterol; 2017; 30(4):442-445. PubMed ID: 28655982
[TBL] [Abstract][Full Text] [Related]
28. The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.
Hijos-Mallada G; Lué A; Velamazan R; Saura N; Abril C; Lorenzo M; Navarro M; Chueca E; Arechavaleta S; Gomollón F; Lanas Á; Sostres C
Front Med (Lausanne); 2021; 8():665786. PubMed ID: 34150803
[No Abstract] [Full Text] [Related]
29. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
[No Abstract] [Full Text] [Related]
30. Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
Ykema BLM; Bisseling TM; Spaander MCW; Moons LMG; van der Biessen-van Beek D; Saveur L; Kerst M; Mulder SF; de Wit R; Zweers D; Meijer GA; Beijnen JH; Lansdorp-Vogelaar I; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
BMC Gastroenterol; 2021 Feb; 21(1):67. PubMed ID: 33579196
[TBL] [Abstract][Full Text] [Related]
31. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.
Cha JM; Lee JI; Joo KR; Shin HP; Park JJ; Jeun JW; Lim JU
Digestion; 2012; 86(4):283-7. PubMed ID: 23051697
[TBL] [Abstract][Full Text] [Related]
32. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
33. Sessile serrated lesions in patients with adenoma on index colonoscopy do not increase metachronous advanced adenoma risk.
Hong SW; Kim J; Lee JY; Lee JS; Chang HS; Park HW; Kim GU; Yoon J; Ye BD; Byeon JS; Myung SJ; Yang SK; Choe J; Yang DH
Dig Endosc; 2022 May; 34(4):850-857. PubMed ID: 34608684
[TBL] [Abstract][Full Text] [Related]
34. Performance value of high risk factors in colorectal cancer screening in China.
Meng W; Cai SR; Zhou L; Dong Q; Zheng S; Zhang SZ
World J Gastroenterol; 2009 Dec; 15(48):6111-6. PubMed ID: 20027686
[TBL] [Abstract][Full Text] [Related]
35. Relationship between serrated polyps and synchronous and metachronous advanced neoplasia: A retrospective study.
Tao EW; Wang YF; Zou TH; Cui Y; Chen YX; Gao QY
J Dig Dis; 2020 Oct; 21(10):558-565. PubMed ID: 32761806
[TBL] [Abstract][Full Text] [Related]
36. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
[No Abstract] [Full Text] [Related]
37. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic drug does not affect the positive predictive value of an immunochemical fecal occult blood test.
Tsuji Y; Gunji T; Sato H; Ono A; Ito T; Ohata K; Yamamichi N; Fujishiro M; Matsuhashi N; Koike K
Dig Endosc; 2014 May; 26(3):424-9. PubMed ID: 24325675
[TBL] [Abstract][Full Text] [Related]
39. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.
Elsafi SH; Alqahtani NI; Zakary NY; Al Zahrani EM
Clin Exp Gastroenterol; 2015; 8():279-84. PubMed ID: 26392783
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
